In a potentially transformative move for healthcare, the NHS is rolling out an “artificial pancreas” for people suffering from type 1 diabetes. Known as the Hybrid Closed Loop (HCL) system, the ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully ...

More than 200 people with diabetes were injured after technology defect caused their insulin pump to unexpectedly shut down, according to the Food and Drug Administration. The software glitch has ...

Within England's National Health Service (NHS), switching from disposable insulin pens to reusable insulin cartridge pens would be either cost-neutral or cost-saving and would reduce plastic waste by ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...

Integrated care systems (ICSs) across England can now bid for their share of £30m to invest in medical technologies. The government hopes the funding will help reduce NHS winter pressures, cut waiting ...

The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes.

Though the smallest of Medtronic’s four core businesses, the diabetes department has taken center stage as of late. Fresh off reaching a resolution with the FDA over a warning letter concerning its ...

SAN DIEGO, September 29, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump ...